REQUEST A DEMO
Total
USD $0.00
Search more companies

Biodrug S. R. O. (Slovakia)

Main Activities: Marketing Research and Public Opinion Polling
Full name: Biodrug S. R. O. Profile Updated: October 16, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Biodrug S. R. O. is an enterprise based in Slovakia. Its main office is in Bratislava. It operates in the Marketing Research and Public Opinion Polling industry. It was first established on November 14, 2014. It currently has a total number of 3 - 4 (2023) employees. There was a net sales revenue increase of 73.15% reported in Biodrug S. R. O.’s latest financial highlights for 2023. During that time, Biodrug S. R. O.’s total assets grew by 20.88%. The net profit margin of Biodrug S. R. O. increased by 3.93% in 2023.

Headquarters
Bozeny Nemcovej, 8
Bratislava; Bratislavsky; Postal Code: 81104

Contact Details: Purchase the Biodrug S. R. O. report to view the information.

Basic Information
Total Employees:
Purchase the Biodrug S. R. O. report to view the information.
Outstanding Shares:
Purchase the Biodrug S. R. O. report to view the information.
Registered Capital:
Purchase the Biodrug S. R. O. report to view the information.
Incorporation Date:
November 14, 2014
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Legal Representative
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Biodrug S. R. O. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency EUR. Absolute financial data is included in the purchased report.
Net sales revenue
73.15%
Total operating revenue
72.81%
Operating profit (EBIT)
331.08%
EBITDA
312.12%
Net Profit (Loss) for the Period
417.51%
Total assets
20.88%
Total equity
43.99%
Operating Profit Margin (ROS)
4.95%
Net Profit Margin
3.93%
Return on Equity (ROE)
22.05%
Debt to Equity Ratio
0.01%
Quick Ratio
0.29%
Cash Ratio
-0.1%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?